Our research is focused on: 1. Identifying genetic markers for chemotherapy induced adverse drug reactions 2. the toxicity of new psychoactive substances & how to use post-mortem metabolomics. We develop prediction models using massive parallel sequencing, single cell RNASeq & high resolution chromatin conformation capture and bioinformatics with large clinical cohorts. In forensics, we develop new techniques using the CBRS platform for neuropharmacology as well as post-mortem metabolomics.
Henrik Green
Linköping University
Key Publications
In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cells
Environmental Toxicology and Pharmacology, 2026
In vitro γ-aminobutyric acid A (GABAA) receptor activity and binding interactions at the α+/γ2– interface of 53 prescription and designer benzodiazepines
Communications Chemistry, 2026
Reproducible metabolomic fingerprinting strengthens postmortem evaluation of insulin intoxication
2026
The human metabolome and machine learning improves predictions of the post-mortem interval
Nature Communications, 2026
Synthetic cannabinoid receptor agonists inhibit the cardiac voltage-gated potassium channel hERG
2025